Skip to content

Search

2018 workshop recap

The Children’s Diabetes Centre’s (CDC) annual workshop provided a great opportunity for diabetes researchers to get together in the one venue to showcase their work recently.

Animas pump offer

Insulin pump company Ypsomed Australia has announced an offer for families currently using an Animas Vibe.

Insulin pumps give better glycaemia outcomes for children than MDI

Children with type 1 diabetes using an insulin pump have better glycaemic control than to those using multiple daily injections (MDI) of insulin, a new Children's Diabetes Centre study has found.

Have your say!

Are you aged 16 to 24 years and live with type 1 diabetes? Do you want to make a difference to the mental health and wellbeing of other young people living with a chronic condition like diabetes, asthma, heart disease, chronic fatigue, chronic pain or an autoimmune disease?

Ready for a sea-faring adventure?

Diabetes WA and Leeuwin Ocean Adventure Foundation are on the hunt for two young people aged 16-18 years with type 1 diabetes to participate in the Leeuwin Ocean Adventure Youth Explorer Voyage in the upcoming October school holidays.

Is prolonged high glucose really that bad for you?

Our researchers are trying to find out, but we need your help for a new study looking at oxidative stress, blood glucose fluctuations and how it affects people living with type 1 diabetes.

Diabetes contact numbers

There are several phone numbers to contact staff for assistance at Perth Children’s Hospital’s Endocrinology and Diabetes Department.

Capacity Building Grants

The Rio Tinto Children's Diabetes Centre; a Breakthrough T1D Centre of Excellence is excited to announce the first round of capacity building grant recipients.

Community of Practice

Our goal is to accelerate the dissemination and implementation of evidence-based models of care for children and young people living with Type 1 Diabetes.

Supporting Families Project

Proudly funded by a Telethon Trust Research Grant, the Supporting Families project started in 2024 with the aim of co-designing a new clinical pathway for children with early stage type 1 diabetes (T1D).